Effects of pesticides on prostate cancer progression in PTEN mutant mice

农药对 PTEN 突变小鼠前列腺癌进展的影响

基本信息

  • 批准号:
    7814051
  • 负责人:
  • 金额:
    $ 31.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-25 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application addresses broad Challenge Area (15) Translational Science and specific Challenge Topic, 15- ES-101*: Effects of Environmental Exposures on Phenotypic Outcomes Using Non-Human Models. Farmers as a group have the highest occupational risk for prostate cancer, but the causes for this are unknown. The Agricultural Health Study associated exposure to certain organophosphorothioate pesticides with increased prostate cancer risk in farmers and professional pesticide applicators with a first-degree family history of prostate cancer. These findings indicate that exposure to these environmental contaminants may interact with a genetic predisposition toward prostate cancer, but the biologic mechanism(s) by which this might occur remain unclear. This information is critical not only for better defining the risks posed by these pesticides for farm workers and others exposed to these chemicals, but also may advance our understanding of prostate cancer progression in the general population. Experimental exploration of the mechanistic links between pesticide exposure and prostate cancer progression will be difficult in humans. Therefore, the objective of this proposal is to test the hypothesis that exposure to organophosphorothioates accelerates prostate cancer progression in a mouse model genetically predisposed to develop premalignant prostate lesions (B6:PTEN/luc) in order to establish an experimental platform for exploring these links. Our model employs sophisticated imaging technology which can be used to rapidly assess the effects of exposures to environmental challenges on prostate cancer progression. This model is generally applicable to evaluating other environmental exposures and can be used in ways not possible in humans to understand the mechanistic links between environmental exposures and the etiology of prostate cancer. PUBLIC HEALTH RELEVANCE: Epidemiologic studies indicate that farmers and others occupationally exposed to certain organophosphorothioate pesticides may have further increased risk for prostate cancer when there is a first degree family history of this disease. Because the mechanistic basis of this finding will be difficult to determine in humans, here we will explore whether exposure of mice genetically predisposed to develop prostate cancer to these pesticides affects disease progression. Elucidating the mechanisms by which certain pesticides influence prostate cancer progression may impact the prevention, detection, and treatment of this disease.
描述(由申请人提供):本申请涉及广泛的挑战领域(15)转化科学和特定的挑战主题,15- ES-101*:环境暴露对使用非人类模型的表型结果的影响。农民作为一个群体,患前列腺癌的职业风险最高,但其原因尚不清楚。农业健康研究将接触某些有机硫代磷农药与具有一级前列腺癌家族史的农民和专业农药施用者的前列腺癌风险增加联系起来。这些发现表明,暴露于这些环境污染物可能与前列腺癌的遗传易感性相互作用,但这种情况可能发生的生物学机制仍不清楚。这些信息不仅对于更好地确定这些农药对农场工人和其他暴露于这些化学品的人构成的风险至关重要,而且还可以促进我们对一般人群中前列腺癌进展的理解。在人类中,对农药暴露与前列腺癌进展之间的机制联系进行实验探索将是困难的。因此,本提案的目的是检验暴露于有机硫代磷酸酯加速前列腺癌进展的假设,在遗传上倾向于发展癌前前列腺病变(B6:PTEN/luc)的小鼠模型中,以建立探索这些联系的实验平台。我们的模型采用了先进的成像技术,可用于快速评估暴露于环境挑战对前列腺癌进展的影响。该模型通常适用于评估其他环境暴露,并且可以以人类不可能的方式使用,以了解环境暴露与前列腺癌病因之间的机制联系。 公共卫生相关性:流行病学研究表明,农民和其他职业接触某些有机硫代磷农药的人,如果有一级前列腺癌家族史,患前列腺癌的风险可能会进一步增加。由于这一发现的机制基础将难以在人类中确定,在这里,我们将探讨暴露于遗传上易患前列腺癌的小鼠是否会影响疾病的进展。阐明某些农药影响前列腺癌进展的机制可能会影响这种疾病的预防,检测和治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael D Henry其他文献

Michael D Henry的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael D Henry', 18)}}的其他基金

Influence of hemodynamic shear stress on circulating tumor cells
血流动力学剪切应力对循环肿瘤细胞的影响
  • 批准号:
    10442218
  • 财政年份:
    2022
  • 资助金额:
    $ 31.89万
  • 项目类别:
Influence of hemodynamic shear stress on circulating tumor cells
血流动力学剪切应力对循环肿瘤细胞的影响
  • 批准号:
    10573281
  • 财政年份:
    2022
  • 资助金额:
    $ 31.89万
  • 项目类别:
Improved detection of bladder cancer recurrence using a biophysical biomarker
使用生物物理生物标志物改进膀胱癌复发的检测
  • 批准号:
    9988591
  • 财政年份:
    2017
  • 资助金额:
    $ 31.89万
  • 项目类别:
Effects of fluid shear stress on circulating tumor cells
流体剪切应力对循环肿瘤细胞的影响
  • 批准号:
    9111247
  • 财政年份:
    2016
  • 资助金额:
    $ 31.89万
  • 项目类别:
(PQC2) Resistance to fluid shear stress: a novel biomarker of cancer cells
(PQC2) 对流体剪切应力的抵抗力:癌细胞的新型生物标志物
  • 批准号:
    8589754
  • 财政年份:
    2013
  • 资助金额:
    $ 31.89万
  • 项目类别:
(PQC2) Resistance to fluid shear stress: a novel biomarker of cancer cells
(PQC2) 对流体剪切应力的抵抗力:癌细胞的新型生物标志物
  • 批准号:
    8721904
  • 财政年份:
    2013
  • 资助金额:
    $ 31.89万
  • 项目类别:
Effects of pesticides on prostate cancer progression in PTEN mutant mice
农药对 PTEN 突变小鼠前列腺癌进展的影响
  • 批准号:
    7938731
  • 财政年份:
    2009
  • 资助金额:
    $ 31.89万
  • 项目类别:
Role of Dystroglycan in Prostate Cancer Progression
肌营养不良聚糖在前列腺癌进展中的作用
  • 批准号:
    7655510
  • 财政年份:
    2008
  • 资助金额:
    $ 31.89万
  • 项目类别:
Mouse model of obesity and prostate cancer progression.
肥胖和前列腺癌进展的小鼠模型。
  • 批准号:
    7742984
  • 财政年份:
    2008
  • 资助金额:
    $ 31.89万
  • 项目类别:
Role of Dystroglycan in Prostate Cancer Progression
肌营养不良聚糖在前列腺癌进展中的作用
  • 批准号:
    8071515
  • 财政年份:
    2008
  • 资助金额:
    $ 31.89万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了